INR 127.0
(13.54%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 36.28 Million INR | 50.23% |
2022 | 153.52 Million INR | 24.65% |
2021 | 123.16 Million INR | 12.01% |
2020 | 109.95 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 13.12 Million INR | -65.96% |
2023 Q1 | 44.8 Million INR | 1659.01% |
2023 Q4 | 38.54 Million INR | -37.69% |
2023 Q3 | 61.86 Million INR | -6.39% |
2023 Q2 | 66.08 Million INR | 47.48% |
2023 FY | 230.63 Million INR | 50.23% |
2022 Q2 | 55.46 Million INR | 0.0% |
2022 FY | 153.52 Million INR | 24.65% |
2022 Q4 | -2.87 Million INR | -104.7% |
2022 Q3 | 61.2 Million INR | 10.35% |
2021 FY | 123.16 Million INR | 12.01% |
2020 FY | 109.95 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Ajanta Pharma Limited | 30.46 Billion INR | 99.881% |
Amrutanjan Health Care Limited | 1.09 Billion INR | 96.698% |
Sigachi Industries Limited | 579.88 Million INR | 93.742% |
Bal Pharma Limited | 389.89 Million INR | 90.693% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 98.292% |
Medico Remedies Limited | 161.84 Million INR | 77.578% |
Lasa Supergenerics Limited | 291.17 Million INR | 87.537% |
Venus Remedies Limited | 1.91 Billion INR | 98.106% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 98.821% |
Alpa Laboratories Limited | 156.14 Million INR | 76.76% |
Nectar Lifesciences Limited | 625.55 Million INR | 94.199% |
Shilpa Medicare Limited | 2.18 Billion INR | 98.336% |
Aarti Drugs Limited | 1.16 Billion INR | 96.892% |
Lupin Limited | 95.67 Billion INR | 99.962% |
Aurobindo Pharma Limited | 39.23 Billion INR | 99.908% |
Zydus Lifesciences Limited | 43.17 Billion INR | 99.916% |
Windlas Biotech Limited | 1 Billion INR | 96.395% |
Suven Life Sciences Limited | 109.75 Million INR | 66.935% |
Eris Lifesciences Limited | 4.94 Billion INR | 99.266% |
J. B. Chemicals & Pharmaceuticals Limited | 8.41 Billion INR | 99.569% |
Solara Active Pharma Sciences Limited | 4.57 Billion INR | 99.208% |
Ipca Laboratories Limited | 13.91 Billion INR | 99.739% |
Bliss GVS Pharma Limited | 1.41 Billion INR | 97.443% |
Achyut Healthcare Limited | 1.6 Million INR | -2155.376% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.976% |
Bajaj HealthCare Limited | 985.34 Million INR | 96.317% |
RPG Life Sciences Limited | 1.63 Billion INR | 97.781% |
Mankind Pharma Limited | 23.15 Billion INR | 99.843% |
Laurus Labs Limited | 3.01 Billion INR | 98.795% |
Piramal Pharma Limited | 19.91 Billion INR | 99.818% |
Syncom Formulations (India) Limited | 942.39 Million INR | 96.149% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 99.831% |
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 99.771% |
Glenmark Pharmaceuticals Limited | 67.56 Billion INR | 99.946% |
Unichem Laboratories Limited | 6.72 Billion INR | 99.46% |
Sequent Scientific Limited | 2.9 Billion INR | 98.749% |
Novartis India Limited | 470.1 Million INR | 92.281% |
Wanbury Limited | 1.16 Billion INR | 96.874% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | 97.413% |
Wockhardt Limited | 6.4 Billion INR | 99.433% |
Themis Medicare Limited | 782.85 Million INR | 95.365% |
Jagsonpal Pharmaceuticals Limited | 773.41 Million INR | 95.308% |
Jubilant Pharmova Limited | 14.45 Billion INR | 99.749% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 99.688% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 99.962% |
Divi's Laboratories Limited | 14.17 Billion INR | 99.744% |
NATCO Pharma Limited | 10.05 Billion INR | 99.639% |
Gufic Biosciences Limited | 1.07 Billion INR | 96.633% |
IOL Chemicals and Pharmaceuticals Limited | 1.09 Billion INR | 96.697% |
Ind-Swift Limited | 946.56 Million INR | 96.166% |
Procter & Gamble Health Limited | 2.99 Billion INR | 98.789% |
FDC Limited | 5.34 Billion INR | 99.322% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | 21.378% |
Granules India Limited | 7.18 Billion INR | 99.495% |
Medicamen Biotech Limited | 335.16 Million INR | 89.173% |
Alkem Laboratories Limited | 32.83 Billion INR | 99.889% |
AstraZeneca Pharma India Limited | 2.6 Billion INR | 98.604% |
Biofil Chemicals and Pharmaceuticals Limited | 16.2 Million INR | -123.872% |
Brooks Laboratories Limited | 51.18 Million INR | 29.095% |
Megasoft Limited | 49.52 Million INR | 26.73% |
ZIM Laboratories Limited | 1.01 Billion INR | 96.418% |
Strides Pharma Science Limited | 9.16 Billion INR | 99.604% |
Neuland Laboratories Limited | 2.92 Billion INR | 98.761% |
Morepen Laboratories Limited | 1.98 Billion INR | 98.174% |
Hikal Limited | 2.48 Billion INR | 98.54% |
Indoco Remedies Limited | 4.74 Billion INR | 99.236% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 98.82% |
Kilitch Drugs (India) Limited | 412.42 Million INR | 91.201% |
Mangalam Drugs & Organics Limited | 676.14 Million INR | 94.633% |
Hester Biosciences Limited | 908.84 Million INR | 96.007% |